260 related articles for article (PubMed ID: 18413137)
41. Collaborative study for the establishment of Infliximab Biological Reference Preparation Batch 1.
Wadhwa M; Rigsby P; Behr-Gross ME
Pharmeur Bio Sci Notes; 2020; 2020():49-52. PubMed ID: 32459170
[TBL] [Abstract][Full Text] [Related]
42. Calibration of the Ph. Eur. human coagulation Factor VIII concentrate BRP batch 5.
Raut S; Costanzo A; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2017; 2017():1-11. PubMed ID: 28279252
[TBL] [Abstract][Full Text] [Related]
43. Collaborative study for the calibration of Ph. Eur. Heparin Low-Molecular-Mass for Assay Biological Reference Preparation batch 11.
Terao E; Regourd E
Pharmeur Bio Sci Notes; 2022; 2022():22-31. PubMed ID: 35481431
[TBL] [Abstract][Full Text] [Related]
44. Calibration of Ph. Eur. BRP batch 4 for oral poliomyelitis vaccine (OPV).
Fiore L; De Dominicis A; Daas A; Costanzo A
Pharmeur Bio Sci Notes; 2014; 2014():18-38. PubMed ID: 25655241
[TBL] [Abstract][Full Text] [Related]
45. Collaborative study for the establishment of the Ph. Eur. Hepatitis E virus RNA for NAT testing biological reference preparation batch 1.
Baylis SA; Terao E; Blümel J; Hanschmann KO
Pharmeur Bio Sci Notes; 2017; 2017():12-28. PubMed ID: 28279253
[TBL] [Abstract][Full Text] [Related]
46. Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay.
Markey K; Douglas-Bardsley A; Hockley J; Le Tallec D; Costanzo A
Pharmeur Bio Sci Notes; 2018; 2018():112-123. PubMed ID: 30272557
[TBL] [Abstract][Full Text] [Related]
47. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).
Stalder J; Costanzo A; Daas A; Rautmann G; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187
[TBL] [Abstract][Full Text] [Related]
48. Collaborative study to establish human immunoglobulin BRP batch 3 and human immunoglobulin (molecular size) BRP batch 1.
Sandberg E; Daas A; Behr-Gross ME;
Pharmeuropa Bio; 2006 Nov; 2006(1):37-48. PubMed ID: 17270130
[TBL] [Abstract][Full Text] [Related]
49. Establishment of a replacement batch for heparin sodium biological reference preparation.
Behr-Gross ME; Daas A
Pharmeuropa Bio; 2007 Dec; 2007(1):19-28. PubMed ID: 18413135
[TBL] [Abstract][Full Text] [Related]
50. Collaborative study for the establishment of replacement batches of Ph. Eur. Heparin Low-Molecular-Mass for Calibration CRS.
Caruncho Garcia-Moreno S; Mulloy B; Rodrigo-Castro I; Denault W; Le Tallec D; Terao E
Pharmeur Bio Sci Notes; 2023; 2023():81-111. PubMed ID: 38037758
[TBL] [Abstract][Full Text] [Related]
51. Establishment of Pertussis toxin BRP batch 2 for CHO clustering assay.
Wall M; Costanzo A; Le Tallec D; Isbrucker R
Pharmeur Bio Sci Notes; 2021; 2021():69-87. PubMed ID: 33934749
[TBL] [Abstract][Full Text] [Related]
52. Collaborative study for the calibration of Ph. Eur. Heparin Sodium Biological Reference Preparation batch 4.
Lièvre V; Goujon N; Le Tallec D; Terao E
Pharmeur Bio Sci Notes; 2021; 2021():167-183. PubMed ID: 34802510
[TBL] [Abstract][Full Text] [Related]
53. Establishment of hepatitis A vaccine (inactivated, non-adsorbed) BRP batches 2 and 3.
Morgeaux S; Manniam I; Variot P; Buchheit KH; Daas A; Wierer M; Costanzo A
Pharmeur Bio Sci Notes; 2015; 2015():118-30. PubMed ID: 26830162
[TBL] [Abstract][Full Text] [Related]
54. Production and characterisation of a candidate hyper-immune serum for the replacement of the Bordetella pertussis mouse antiserum Biological Reference Preparation.
Morgeaux S; Bornstein N; Mourton-Gilles C; Chagnaud P; Charbonneau J; Maurin J; Daas A; Variot P; Behr-Gross ME
Pharmeur Bio Sci Notes; 2020; 2020():141-160. PubMed ID: 32788037
[TBL] [Abstract][Full Text] [Related]
55. Collaborative study for the establishment of Ph. Eur. Human albumin (molecular size) Biological Reference Preparation batches 1, 2 and 3.
Sinitskaya N; Regourd E; Wierer M; Behr-Gross ME; Lièvre V
Pharmeur Bio Sci Notes; 2021; 2021():184-198. PubMed ID: 34913434
[TBL] [Abstract][Full Text] [Related]
56. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
[TBL] [Abstract][Full Text] [Related]
57. Establishment of the Ph. Eur. BRP for varicella vaccine batch 1.
Akkermans AM; Waeterloos G; Kemiha K; Daas A; Milne C
Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):41-54. PubMed ID: 20144451
[TBL] [Abstract][Full Text] [Related]
58. Collaborative study for the establishment of Etanercept Biological Reference Preparation Batch 1.
Wadhwa M; Rigsby P; Behr-Gross ME
Pharmeur Bio Sci Notes; 2020; 2020():203-205. PubMed ID: 33021469
[TBL] [Abstract][Full Text] [Related]
59. Establishment of a candidate equine influenza Florida Clade 2 strain A/eq/Richmond/1/07 horse antiserum as Ph. Eur. Biological Reference Preparation/OIE International Reference Reagent.
Paillot R; Regourd E; Behr-Gross ME
Pharmeur Bio Sci Notes; 2020; 2020():125-140. PubMed ID: 32677612
[TBL] [Abstract][Full Text] [Related]
60. Collaborative study for the establishment of Ph. Eur. Biological Reference Preparation for Human tetanus immunoglobulin batch 2.
Stickings P; Tierney R; Hockley J; Rigsby P; Terao E
Pharmeur Bio Sci Notes; 2024; 2024():1-11. PubMed ID: 38533744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
